Heidelberg Pharma AG (ETR:HPHA) | WebDisclosure

Basculer en Français

9835	Companies
197436	Keywords
128527	Articles
105010	Press releases

Home
Companies
Heidelberg Pharma AG

PRESS RELEASE

published on 05/15/2025 at 14:31, 8 months 25 days ago

Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
Heidelberg Pharma AG reports on the results of the Ordinary Annual General Meeting 2025 and the appointment of a new Supervisory Board. Key decisions made include new board members and Dr. Karl Benedikt Biesinger elected as Chairman

Annual General Meeting Supervisory Board Heidelberg Pharma AG ADCs Dr. Karl Benedikt Biesinger
BRIEF

published on 05/14/2025 at 18:45, 8 months 26 days ago

Heidelberg Pharma dévoilera les données cliniques du HDP-101 à l'EHA 2025

Essai Clinique Heidelberg Pharma HDP-101 Myélome Multiple EHA 2025
BRIEF

published on 05/14/2025 at 18:45, 8 months 26 days ago

Heidelberg Pharma to Unveil Clinical Data on HDP-101 at EHA 2025

Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma EHA 2025
PRESS RELEASE

published on 05/14/2025 at 18:40, 8 months 26 days ago

Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
Heidelberg Pharma to present new clinical data on lead ATAC candidate HDP-101 at EHA 2025. Promising results in Multiple Myeloma treatment. R&D webinar to follow

Clinical Data Heidelberg Pharma Multiple Myeloma ATAC Candidate EHA 2025
BRIEF

published on 04/24/2025 at 07:21, 9 months 16 days ago

Heidelberg Pharma AG's First Quarter Financial Report for 2025

Financial Statement Clinical Trials Heidelberg Pharma 2025 Outlook ADC Programs
BRIEF

published on 04/24/2025 at 07:21, 9 months 16 days ago

Rapport financier du premier trimestre 2025 de Heidelberg Pharma AG

Essais Cliniques Heidelberg Pharma Perspectives 2025 État Financier Programmes ADC
PRESS RELEASE

published on 04/24/2025 at 07:16, 9 months 16 days ago

Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
Heidelberg Pharma AG reports positive results for ATAC candidates HDP-101 and HDP-102 in Q1 2025, extends cash reach through financing activities, and progresses towards market approval for TLX250-CDx

HDP-101 Heidelberg Pharma AG TLX250-CDx ATAC Candidates HDP-102
BRIEF

published on 03/26/2025 at 09:28, 10 months 15 days ago

Heidelberg Pharma to Showcase ADC Innovations at AACR 2025

Heidelberg Pharma ADC Technology HDP-201 AACR 2025 NAMPT Inhibitors
BRIEF

published on 03/26/2025 at 09:28, 10 months 15 days ago

Heidelberg Pharma présentera ses innovations ADC à l'AACR 2025

Heidelberg Pharma HDP-201 Technologie ADC AACR 2025 Inhibiteurs De NAMPT
PRESS RELEASE

published on 03/26/2025 at 09:23, 10 months 15 days ago

Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
Heidelberg Pharma AG to present latest ADC research results and advancements at AACR Annual Meeting 2025, showcasing Exatecan-based and Amanitin-based ADC technology platforms

Heidelberg Pharma ADC AACR Annual Meeting 2025 Exatecan-based ADC Amanitin-based ADC

Accesswire

Published on 02/10/2026 at 13:30, 17 minutes ago

Revival Gold Intercepts 1.0 g/t Gold Over 30 Meters and Extends Mineralization at Mercur Project in Utah
Published on 02/10/2026 at 13:30, 17 minutes ago

Metallic Minerals Provides Keno Silver Project Update and Details 2026 Exploration Plans
Published on 02/10/2026 at 13:00, 47 minutes ago

Kalo Gold Advances 2026 Target Development at Vatu Aurum; Lidar and Orthophotography Completed; Airborne Geophysics Planned for February
Published on 02/10/2026 at 13:00, 47 minutes ago

NOA Lithium Announces Additional Warrant Exercises for $818,000
Published on 02/10/2026 at 13:00, 47 minutes ago

Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion

View all ACCESSWIRE

EQS Group

Published on 02/10/2026 at 13:35, 11 minutes ago

Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:15, 32 minutes ago

SCOPE’s Ultra-Luxury Residential Performance Underscores Strong Investor Confidence in Thailand’s Prime Market
Published on 02/10/2026 at 13:08, 38 minutes ago

Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:05, 42 minutes ago

Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:03, 43 minutes ago

EQS-Adhoc: Commerzbank Aktiengesellschaft: Commerzbank decides to implement a further share buyback

Les Echos

Published on 02/09/2026 at 18:00, 19 hours 47 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago

Déclaration des droits de vote à fin janvier 2026

View all LES ECHOS COMFI WIRE